Globus Medical, Inc.
GMED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $118,966 | $202,846 | $75,462 | $26,505 |
| Dep. & Amort. | $71,126 | $70,631 | $66,074 | $68,228 |
| Deferred Tax | $41,761 | -$41,745 | $509 | -$33,179 |
| Stock-Based Comp. | $11,538 | $13,617 | $13,206 | $11,907 |
| Change in WC | $1,741 | -$56,628 | $9,601 | $27,265 |
| Other Non-Cash | $4,563 | -$110,856 | $12,448 | $109,613 |
| Operating Cash Flow | $249,695 | $77,865 | $177,300 | $210,339 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$35,817 | -$46,562 | -$36,103 | -$17,111 |
| Net Acquisitions | $255,214 | -$252,546 | $0 | $0 |
| Inv. Purchases | -$35,359 | $0 | -$1,750 | -$100,138 |
| Inv. Sales/Matur. | $0 | $0 | $174,238 | $13,127 |
| Other Inv. Act. | -$259,880 | $0 | -$5,000 | $0 |
| Investing Cash Flow | -$75,842 | -$299,108 | $131,385 | -$104,122 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$449,985 | $0 |
| Stock Issued | $11,079 | $0 | $0 | $0 |
| Stock Repurch. | -$40,000 | -$25,000 | -$190,451 | -$1,000 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,121 | $63 | $5,040 | $60,733 |
| Financing Cash Flow | -$32,042 | -$24,937 | -$635,396 | $59,733 |
| Forex Effect | $512 | $14,360 | $3,539 | -$4,278 |
| Net Chg. in Cash | $142,323 | -$231,820 | -$323,172 | $161,672 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $229,446 | $461,266 | $784,438 | $622,766 |
| End Cash | $371,769 | $229,446 | $461,266 | $784,438 |
| Free Cash Flow | $218,878 | $31,303 | $136,197 | $193,228 |